Advanced Search
Contact | Corporate | Help

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Sponsors:
  • Leo W. Jenkins Cancer Center
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Cervical Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Carboplatin
  • Radiation: Radiation Therapy
Enrollment:
30

Additional information about NCT00600210.


SourceSolution © 2008-2012